82 related articles for article (PubMed ID: 578071)
1. [Studies on serum AT III levels in various diseases (author's transl)].
Yamaguchi T; Konishi M; Kuto M; Shima H; Kato F
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):255-60. PubMed ID: 578071
[No Abstract] [Full Text] [Related]
2. [Plasma and serum antithrombin III levels in cerebrovascular patients (author's transl)].
Takamatsu S; Satoh K; Sakuta S; Mizuno S; Sugawara H
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):238-43. PubMed ID: 578069
[No Abstract] [Full Text] [Related]
3. [Determination and clinical evaluation of sialic acids in serum (author's transl)].
Morishita Y; Nakane K; Kōsaka A
Rinsho Byori; 1976 May; 24(5):411-4. PubMed ID: 987334
[No Abstract] [Full Text] [Related]
4. [Clinical significance of serum alpha-fetoprotein by hemagglutinin reaction in various diseases (author's transl)].
Aoki T
Rinsho Byori; 1977 Apr; 25(4):329-33. PubMed ID: 69734
[No Abstract] [Full Text] [Related]
5. [Changes of antithrombin III in the thrombotic diathesis (author's transl)].
Oguri T; Kato R; Sugawara Y; Sugie I; Yamamoto H
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):244-7. PubMed ID: 578070
[No Abstract] [Full Text] [Related]
6. [The significance of haptoglobin determination in clinical practice (author's transl)].
Hromec A; Horák I; Cicmancová L
Bratisl Lek Listy; 1975 Nov; 64(5):534-43. PubMed ID: 1192206
[No Abstract] [Full Text] [Related]
7. [Studies of the behavior of PA, RBP in the blood in various liver diseases (author's transl)].
Shingami T; Morita N; Shiwaku Y; Nakao Y; Hashimoto S
Igaku Kenkyu; 1979 Sep; 49(3):255-67. PubMed ID: 575752
[No Abstract] [Full Text] [Related]
8. [Immunological assay of antithrombin (anthrombin III and alpha2-macroglobulin) (author's transl)].
Meguro T; Yamada K; Shirahata A
Rinsho Byori; 1975 Aug; 23(8):635-8. PubMed ID: 811830
[No Abstract] [Full Text] [Related]
9. [Clinical significance of alpha-fetoprotein (author's transl)].
Endō Y; Kanai K
Rinsho Byori; 1975 May; 23(5):356-64. PubMed ID: 51942
[No Abstract] [Full Text] [Related]
10. [Study of antithrombin III in pancreatitis (author's transl)].
Uehara S; Hirayama A
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):248-54. PubMed ID: 70146
[No Abstract] [Full Text] [Related]
11. [Effects of alpha2-macroglobulin and FDP on the antithrombin III assay system (author's transl)].
Yoshida N; Tachiya K; Moroi M; Matsuda M; Aoki N
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):197-201. PubMed ID: 70144
[No Abstract] [Full Text] [Related]
12. [Exogenous heparin and antithrombin activity (author's transl)].
Nakagawa M; Okada T; Okuda S; Nishizawa A; Watada M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):207-12. PubMed ID: 578066
[No Abstract] [Full Text] [Related]
13. [Congenital excess of anti-thrombin III associated to haemorrhagic diathesis. report of one case and a review of the literature (author's transl)].
Prados Madrona D; Rodríguez Fernández M; Núnez Roldan A; Canavate Yllescas M
Sangre (Barc); 1976; 21(2):387-98. PubMed ID: 948785
[No Abstract] [Full Text] [Related]
14. [Serum ferritin in patients with hepatobiliary diseases (author's transl)].
Uchiyama Y; Kanazawa S; Okuda K
Rinsho Ketsueki; 1980 Aug; 21(8):1104-11. PubMed ID: 6160268
[No Abstract] [Full Text] [Related]
15. [Prothrombin (factor II) in hepatic diseases].
Mannucci PM; Lobina GF; Craveri A; Bragotti R; Cerrini R
G Clin Med; 1968 Dec; 49(12):1311-25. PubMed ID: 5737500
[No Abstract] [Full Text] [Related]
16. [Fetal haemoglobin levels in acquired and congenital haematological diseases and malignant tumours in adults (author's transl)].
Mohamed S; Sinzinger H; Scheiner C; Pietschmann H
Wien Klin Wochenschr; 1976 Aug; 88(15):485-8. PubMed ID: 1087072
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiological analysis of acute phase reactants(I)--Clinical assessment of alpha2/alpha1 ratio obtained by serum protein electrophoresis (author's transl)].
Kanno T; Kano S; Mimori M; Horii K; Ohtake T
Rinsho Byori; 1977 Sep; 25(9):763-6. PubMed ID: 72836
[No Abstract] [Full Text] [Related]
18. [Study on alpha-fetoprotein in serum of liver diseases (author's transl)].
Koyama T; Ohya T; Tomimura K; Takeyama N; Kikuchi S
Rinsho Byori; 1975 Dec; 23(12):932-4. PubMed ID: 56472
[No Abstract] [Full Text] [Related]
19. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)].
Sakuragawa N; Takahashi K; Hoshiyama M; Matsuoka M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):218-26. PubMed ID: 578067
[No Abstract] [Full Text] [Related]
20. [Fasting and post-prandial serum bile acids as liver function tests in chronic liver diseases (author's transl)].
Poupon RY; Poupon RE; Erlinger S; Darnis F
Gastroenterol Clin Biol; 1978 Nov; 2(11):873-6. PubMed ID: 748077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
